LOXL2 and prostate carcinoma: To demonstrate clinical relevance of LOXL2 we interrogated the prostate cancer RNA-seq data set (n = 492) of The Cancer Genome Atlas (TCGA) for LOXL2 gene expression levels in patients with localized prostate cancer.